We are live on ! Find out more
OCRX

Ocera Therapeutics
OCRX

Delisted

OCRX was delisted on the 8th of December, 2017.

31 hedge funds and large institutions have $21.3M invested in Ocera Therapeutics in 2016 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 10 increasing their positions, 6 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

164% more capital inflows, than outflows

Capital inflows: $935K | Capital outflows: $354K

67% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 6

6% less funds holding

Funds holding: 33 → 31 (-2)

50% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 4

Holders
31
Holders Change
-2
Holders Change %
-6.06%
% of All Funds
0.82%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
2
Increased
10
Reduced
6
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

OCRX Hedge Fund Activity: Q3 2016 in Review

31 of the 3,759 institutional investors tracked by Wall St. Rank reported a position in Ocera Therapeutics (OCRX) for Q3 2016, worth a combined $21.3M — up 45% from $14.7M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of OCRX and 2 opened new positions — a net loss of 2 holders — while 6 trimmed existing stakes and 10 added.

The largest buyer was VHCP Management II, adding an estimated $350K. The largest seller was Bridgeway Capital Management, cutting an estimated $199K.

  • 31 institutional investors held Ocera Therapeutics (OCRX) as of Q3 2016, down from 33 in Q2 2016.
  • Funds reported $21.3M of Ocera Therapeutics stock for Q3 2016, up 45% quarter-over-quarter.
  • 2 funds opened new Ocera Therapeutics positions in Q3 2016 and 4 closed out, a net change of -2 holders.
  • The largest Ocera Therapeutics buyer in Q3 2016 was VHCP Management II, an estimated $350K added.
  • The largest Ocera Therapeutics seller in Q3 2016 was Bridgeway Capital Management, an estimated $199K sold.

Based on aggregated 13F filings for Q3 2016.